An “unexpected” move by the China Food and Drug Administration (CFDA) to reverse-switch two of its leading OTC products, in combination with “persistently weak business development in the US”, caused Bayer’s Consumer Health sales to fall by 2.9% to €5.86 billion in 2017, the German company reported.
An “unexpected” move by the China Food and Drug Administration (CFDA) to reverse-switch two of its leading OTC products, in combination with “persistently weak business development in the US”, caused Bayer’s Consumer Health sales to fall by 2.9% to €5.86 billion in 2017, the German company reported.
The CFDA’s decision in September to reverse-switch to prescription-only status medicines containing ketoconazole and combinations of ketoconazole and clobetasol propionate...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
